Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.61NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.74ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.74NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3181.36China
BM.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.62ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.62NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BA.5.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.13.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.13.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BF.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used